z-logo
open-access-imgOpen Access
Implantable Cardioverter-Defibrillators
Author(s) -
Zachary D. Goldberger,
Rachel Lampert
Publication year - 2006
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.295.7.809
Subject(s) - medicine , cardiac resynchronization therapy , implantable cardioverter defibrillator , sudden cardiac death , randomized controlled trial , ejection fraction , heart failure , medline , cardiology , intensive care medicine , political science , law
Sudden cardiac death (SCD) is a major challenge facing contemporary cardiology. For an increasing number of patients, the current standard of care for the treatment and prevention of SCD is the implantable cardioverter-defibrillator (ICD). Since its introduction, there have been numerous advances in ICD technology, and indications for its use have expanded greatly in the past year.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom